EPHX2 and colorectal carcinoma: We further analyzed the molecular mechanism of EPHX2’s inhibition of the progression of CRC at the cellular level and performed RNA-seq analysis on HCT116 cells stably transfected with EPHX2, with the NC group as control and three cell lines in each group.